HealthTechX Global - Read Johan Ottosson key takeaways from the conference last week:
HealthTech - It was great attending the HealthTechX Global Summit last week at The Hurlingham Club. My key takeaways from panels and discussions: 1) The digital health market has matured, and we are past the funding rounds of 2021 and 2022. Companies need to prove the feasibility of their business cases, have a clear idea of where to scale, and have a clear fundraising strategy. Though the current funding environment is challenging the ones doing well now will probably do well in the future as well 2) Hyperscale is out. In selling to the NHS: sales cycles can take time and companies need to make sure they have enough capital to carry them over that threshold. In collaborations: companies find a smaller area of common interest and grow from there. In international expansion: companies need to have a plan but avoid overexerting themselves and losing focus 3) Though AI in healthcare faces a lot of difficulties (regulation, reimbursement, and increases in costs) it remains a valuable tool for many applications. With a global shortage of clinicians and growing health inequalities AI and healthtech more broadly will have an important role to play, and digital and chronic care are a particularly good match Thanks to an outstanding line up of moderators and speakers including: ➡ noel gordon, Chair Telstra Health UK ➡ Jeanette Kusel, Director NICE - National Institute for Health and Care Excellence ➡ Dr. Ben Maruthappu, CEO and founder Cera ➡ Dr Harpreet Sood, VP Primary Care and Partnerships Huma ➡ Kalle Conneryd Lundgren, COO Kry ➡ Molly Gilmartin, AlbionVC ➡ Ranjan Singh, CEO and co-founder HealthHero ➡ Sokratis Papafloratos, CEO and founder Numan ➡ Stephanie Leung, CEO and founder KareHero ➡ Rajiv Tanna, CPO and co-founder, Birdie ➡ Martin McShane, CMO Optum (UnitedHealth Group) #healthtech #healthcare Fairgrove Partners
